Thymidine-5'-triphosphate (Pubchem)
dNTP Pool
Pool identifier POOL001000
Members of this Pool
Members of control pools
POOL000998
Last modified: 10/Sep/2021
Results
Publication
Thientosapol ES, Bosnjak D, Durack T, Stevanovski I, van Geldermalsen M, Holst J, Jahan Z, Shepard C, Weninger W, Kim B, Brink R, Jolly CJ: SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation., Proc Natl Acad Sci U S A, 2018

PubMed PMCID
Value 17.1527
Dimension fold change
Error (unspecified) 9.7948
Relative compared to control
Data presentation in publication diagram
Source
Source organism mouse (Mus musculus)
Taxonomy 10090
Animal strain C57BL/6 mice
Sample source tissue
Tissue type splenocytes
Cell line/type as in publication C57BL/6; Samhd1 Δ25/Δ25
Compartment whole cell
Experiment Details
Measurement type dNTP incorporation assay
Extraction method methanol
Remarks to measurement type with HIV-1 reverse transcriptase
Growth conditions splenocytes were activated with 20 μg/mL S. typhosa LPS plus 20 ng/mL mouse IL-4 for 24 h; dNTPs were extracted from live cells 2 days after activation
Treatment
Drug/stress type drug
Applied drug LPS, IL-4
Genes and Proteins
Gene name SAMHD1
Gene identifier 56045
Protein name Deoxynucleoside triphosphate triphosphohydrolase SAMHD1
Protein identifier Q60710
Genetic manipulation/variation mutation
Mutation in protein 25-bp frame-shift deletions within Exon 1, homozygous mutation